Sachin D. Patel to acquire equity shares of Gujarat Themis Biosyn Limited from Pharmaceutical Business Group (India) Limited
Sachin D. Patel, belonging to the Promoter Group, is proposing to acquire a portion of equity shares in Gujarat Themis Biosyn Limited from Pharmaceutical Business Group (India) Limited as part of an inter-se transfer among promoters.The proposed acquisition, scheduled between July 21, 2026, and July 31, 2026, involves the purchase of up to 5,25,000 equity shares from Pharmaceutical Business Group (India) Limited. The transaction is valued at up to Rs. 20 Crores, with the proposed acquisition price set at Rs. 382 per equity share. This transfer is designated as an inter se transfer within the Promoter and Promoter Group of Gujarat Themis Biosyn Limited.
The market data provided for comparison shows that the volume weighted average market price for the company over a period of 60 trading days was reported at Rs. 380.37 per equity share.
Shareholding Details Before and After Transaction
The transaction is set to alter the current shareholder structure of Gujarat Themis Biosyn Limited, impacting both the acquirer and the seller.A detailed look at the relevant shareholding details before and after the proposed transfer is presented below:
| Entity | Role | Pre-Transaction Shares | Pre-Transaction % | Post-Transaction Shares | Post-Transaction % |
|---|---|---|---|---|---|
| Sachin D. Patel (Acquirer) | Promoter Group Member | 24,97,200 | 2.29% | 30,22,200 | 2.77% |
| Pharmaceutical Business Group (India) Limited (Seller) | Seller | 5,12,40,000 | 47.02% | 5,07,15,000 | 46.54% |
The transaction is reported as an inter se transfer between the Promoter and the Promoter Group, with Sachin D. Patel acting as the Acquirer. The acquiring party declared that all conditions specified regarding exemptions have been complied with.
GUJTHEM Stock Price Movement
Shares of Gujarat Themis Biosyn Limited are edging higher to ₹373.30 as of 11:40 AM, successfully gaining 0.38% in live trading. The stock price remains volatile intraday, having tested a low of ₹363.90 but peaking at a high of ₹375.15.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.